ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

8 links1 made here, not in the record12 judgments2 judges (the rules as one: Rule based)0 record changes seen
Claude Opus 5.5Rule basedMade here
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT05785741A Study of DB-1310 inAdvanced/Metastatic SolidTumorsDualityBio Inc.Phase 1/Phase 2 · recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›No new version seen since tracking began Sep 25, 2026.CONDITIONSSquamous Cell Carcinoma of …The registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termCarcinoma, Non-Small-Cell L…The registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termBreast NeoplasmsThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termDRUGSINT011847Entry “DB-1310”, read by our name rule›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedTrastuzumabIntervention entry›Nov 2 · Claude Opus 5.5 · Background · partnerNov 18 · Rule based · BackgroundBackground · partnerOsimertinibIntervention entry›Nov 2 · Claude Opus 5.5 · Background · partnerNov 18 · Rule based · BackgroundBackground · partnerCapecitabineIntervention entry›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundTrastuzumab deruxtecanMade here · Found by reading; no entr…›Nov 2 · Claude Opus 5.5 · Background · partnerBackground · partner

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

INT011847

From the registry record2 judgments on this link
Role in the study, from the registry to what was judged
RegistryEntry “DB-1310”the record gives no role
→judged=agrees
How the 2 judgments split100%of judgments with a known value say Tested
Tested · 2

All judgments on this study

WhenLinkJudgeDecisionState
Nov 2INT011847Claude Opus 5.5TestedCurrent
Nov 2TrastuzumabClaude Opus 5.5Background · partnerCurrent
Nov 2OsimertinibClaude Opus 5.5Background · partnerCurrent
Nov 2CapecitabineClaude Opus 5.5BackgroundCurrent
Nov 2Trastuzumab deruxtecanmade hereClaude Opus 5.5Background · partnerCurrent
Nov 14Squamous Cell Carcinoma of Head and NeckRule based · condition-kind ruleFinest filed termCurrent
Nov 14Carcinoma, Non-Small-Cell LungRule based · condition-kind ruleFinest filed termCurrent
Nov 14Breast NeoplasmsRule based · condition-kind ruleFinest filed termCurrent
Nov 18INT011847Rule based · role ruleTestedAgrees
Nov 18TrastuzumabRule based · role ruleBackgroundAgrees
Nov 18OsimertinibRule based · role ruleBackgroundAgrees
Nov 18CapecitabineRule based · role ruleBackgroundAgrees

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

How a condition link is counted

For each condition a study is filed under: whether it is the study's own condition at the finest the study states it, a wider one, a general category, or filed by mistake; and whether it is the main condition, a setting the study names, or only how it was filed.

A decision on file for one study overrides it, with who made it and when.